// App-Quantinova.ai

2600 : Receipt of Maintenance Therapy Is Most Predictive of Survival in Older Acute Lymphoblastic Leukemia Patients Treated with Intensive Induction Chemotherapy Regimens.

Researchers

Presenter

  • Edward A. Stadtmauer

Principal Investigators

  • Alison W. Loren

  • Steven C. Goldstein

  • Noelle V. Frey

  • Sunita D. Nasta

  • David L Porter

  • Donald E Tsai

  • Alexander E Perl

  • Elizabeth Hexner

  • Selina Luger

Medical Centers

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Daunorubicin

  • Methotrexate

  • Vincristine

  • Doxorubicin

  • Cytarabine liposomal

  • Prednisone

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved